Differences in the delivery of medications for opioid use disorder during hospitalization by racial categories: A retrospective cohort analysis

References

• Sordo L, Barrio G, Bravo MJ, et al. Mortality risk during and after opioid substitution treatment: systematic review and meta-analysis of cohort studies. Bmj. 2017;357:j1550.
   PubMed Web of Science ®Google Scholar
• Beetham T, Saloner B, Gaye M, Wakeman SE, Frank RG, Barnett ML. Therapies offered at residential addiction treatment programs in the United States. JAMA 2020;324(8):1251–806.
   Google Scholar
• Busch AB, Greenfield SF, Reif S, Normand S-LT, Huskamp HA. Outpatient care for opioid use disorder among the commercially insured: use of medication and psychosocial treatment. J Subst Abuse Treat. 2020;115:108040.
   PubMedGoogle Scholar
• Mattick RP, Breen C, Kimber J, Davoli M. Buprenorphine maintenance versus placebo or methadone maintenance for opioid dependence. Cochrane Database Syst Rev 2014;2:CD002207.
   PubMed Web of Science ®Google Scholar
• Substance Abuse Mental Health Services Administration. Federal guidelines for opioid treatment programs. In. Vol Vol HHS Publication No.(SMA) PEP 15-FEDGUIDEOTP2015; 2015.
   Google Scholar
• National Academies of Sciences, Engineering, and Medicine. Medications for Opioid Use Disorder save Lives. Washington, DC: The National Academies Press; 2019.
   Google Scholar
• Priest KC. Commentary on Jin et al. (2020): regulatory and allocative policies inform access to opioid agonist therapy. Addiction. 2020;115(12):2255–2256.
   PubMed Web of Science ®Google Scholar
• Hansen H, Roberts SK. Two tiers of biomedicalization: methadone, buprenorphine, and the racial politics of addiction treatment. Adv Med Soc 2012;14(12):79–102.
   Google Scholar
• James K, Jordan A. The opioid crisis in black communities. J Law Med Ethics. 2018;46(2):404–421.
   PubMed Web of Science ®Google Scholar
• Hansen H, Parker C, Netherland J. Race as a Ghost Variable in (White) opioid research. Sci Technol Hum Values. 2020;45(5):848–876.
   Google Scholar
• Netherland J, Hansen HB. The war on drugs that Wasn’t: wasted whiteness, “Dirty Doctors,” and race in media coverage of prescription opioid misuse. Cult Med Psychiatry. 2016;40(4):664–686.
   PubMed Web of Science ®Google Scholar
• Hansen H, Siegel CE, Case BG, Bertollo DN, DiRocco D, Galanter M. Variation in use of buprenorphine and methadone treatment by racial, ethnic, and income characteristics of residential social areas in New York City. J Behav Health Serv Res. 2013;40(3):367–377.
   PubMed Web of Science ®Google Scholar
• Schiff DM, Nielsen T, Hoeppner BB, et al. Assessment of racial and ethnic disparities in the use of medication to treat opioid use disorder among pregnant women in Massachusetts. JAMA Netw Open. 2020;3(5):e205734.
   PubMed Web of Science ®Google Scholar
• Goedel WC, Shapiro A, Cerdá M, Tsai JW, Hadland SE, Marshall BD. Association of racial/ethnic segregation with treatment capacity for opioid use disorder in counties in the United States. JAMA Netw Open. 2020;3(4):e203711.
   PubMed Web of Science ®Google Scholar
• Priest KC, McCarty D, Lovejoy TI. Expanding access to medications for opioid use disorder: program and policy approaches from outside the Veterans Health Administration. J Gen Intern Med. 2020;35(Suppl 3):886–890.
   PubMed Web of Science ®Google Scholar
• Rutherford PA, Provost LP, Kotagal UR, Luther K, Anderson A. Achieving Hospital-Wide Patient Flow. IHI White Paper Cambridge: Institute for Healthcare Improvement. 2017.
   Google Scholar
• Priest KC. Hospital-based services for opioid use disorder: a study of supply-side attributes. Dissertations and Theses. 2019; p. 4829.
   Google Scholar
• Englander H, Weimer M, Solotaroff R, et al. Planning and designing the Improving Addiction Care Team (IMPACT) for hospitalized adults with substance use disorder. J Hosp Med. 2017;12(5):339–342.
   PubMed Web of Science ®Google Scholar
• Velez CM, Nicolaidis C, Korthuis PT, Englander H. It’s been an experience, a life learning experience: a qualitative study of hospitalized patients with substance use disorders. J Gen Intern Med. 2017;32(3):296–303.
   PubMed Web of Science ®Google Scholar
• Liebschutz JM, Crooks D, Herman D, et al. Buprenorphine treatment for hospitalized, opioid-dependent patients: a randomized clinical trial. JAMA Intern Med. 2014;174(8):1369–1376.
   PubMed Web of Science ®Google Scholar
• Englander H, Dobbertin K, Lind BK, et al. Inpatient addiction medicine consultation and post-hospital substance use disorder treatment engagement: a propensity-matched analysis. J Gen Intern Med. 2019;34(12):2796–2803.
   PubMed Web of Science ®Google Scholar
• Priest KC, Lovejoy TI, Englander H, Shull S, McCarty D. Opioid agonist therapy during hospitalization within the Veterans Health Administration: a pragmatic retrospective cohort analysis. J Gen Intern Med. 2020;35(8):2365–2374.
   PubMed Web of Science ®Google Scholar
• Boyd RW, Lindo EG, Weeks LD, McLemore MR. On racism: a new standard for publishing on racial health inequities. Health Affairs Blog 2020;10.
   Google Scholar
• Kaplan JB, Bennett T. Use of race and ethnicity in biomedical publication. JAMA 2003;289(20):2709–2716.
   PubMed Web of Science ®Google Scholar
• Jones CP. Levels of racism: a theoretic framework and a gardener’s tale. Am J Public Health 2000;90(8):1212.
   PubMed Web of Science ®Google Scholar
• Jones CP. Confronting institutionalized racism. Phylon. 2002;50(1/2):7–22.
   Google Scholar
• Kilbourne AM, Switzer G, Hyman K, Crowley-Matoka M, Fine MJ. Advancing health disparities research within the health care system: a conceptual framework. Am J Public Health. 2006;96(12):2113–2121.
   PubMed Web of Science ®Google Scholar
• Stata: Statsitics/Data Analysis [computer program]. College Station: StatCorp LLC; 2017.
   Google Scholar
• R: A language and environment for statistical computing [computer program]. Vienna, Austria: R Foundation for Statistical Computing; 2018.
   Google Scholar
• Wickham H, Averick M, Bryan J, et al. Welcome to the tidyverse. Joss. 2019;4(43):1686.
   Google Scholar
• Wickham H. The split-apply-combine strategy for data analysis. J Stat Soft. 2011;40(1):i01.
   Web of Science ®Google Scholar
• Fox J, Weisberg S. An [R] Companion to Applied Regression, Third Edition. Vol 2. Thousand Oaks, CA: SAGE Publications; 2019.
   Google Scholar
• dplyr: A Grammar of Data Manipulation. [computer program]. Version R package version 0.8.32019; 2019.
   Google Scholar
• icd: Comorbidity Calculations and Tools for ICD-9 and ICD-10 Codes [computer program]. 2019.
   Google Scholar
• Dormann CF, Elith J, Bacher S, et al. Collinearity: a review of methods to deal with it and a simulation study evaluating their performance. Ecography 2013;36(1):27–46.
   Web of Science ®Google Scholar
• Fagerland MW, Hosmer DW. A generalized Hosmer–Lemeshow goodness-of-fit test for multinomial logistic regression models. Stata J. 2012;12(3):447–453.
   Web of Science ®Google Scholar
• Andersen R. Nonparametric methods for modeling nonlinearity in regression analysis. Annu Rev Sociol. 2009;35(1):67–85.
   Google Scholar
• Rogers W. Regression standard errors in clustered samples. Stata technical bulletin 1994;3(13).
   Google Scholar
• Manhapra A, Stefanovics E, Rosenheck R. Initiating opioid agonist treatment for opioid use disorder nationally in the Veterans Health Administration: Who gets what? Subst Abus. 2020;41(1):110–120.
   PubMed Web of Science ®Google Scholar
• Finlay AK, Harris AH, Timko C, et al. Disparities in access to medications for opioid use disorder in the Veterans Health Administration. J Addict Med. 2021;15(2):143–149.
   PubMed Web of Science ®Google Scholar
• Essien UR, Sileanu FE, Zhao X, et al. Racial/ethnic differences in the medical treatment of opioid use disorders within the VA healthcare system following non-fatal opioid overdose. J Gen Intern Med. 2020;35(5):1537–1544.
   PubMedGoogle Scholar
• Manhapra A, Quinones L, Rosenheck R. Characteristics of veterans receiving buprenorphine vs. methadone for opioid use disorder nationally in the Veterans Health Administration. Drug Alcohol Depend. 2016;160:82–89.
   PubMed Web of Science ®Google Scholar
• Manhapra A, Petrakis I, Rosenheck R. Three-year retention in buprenorphine treatment for opioid use disorder nationally in the Veterans Health Administration . Am J Addict. 2017;26(6):572–580.
   PubMed Web of Science ®Google Scholar
• Marchand K, Beaumont S, Westfall J, et al. Conceptualizing patient-centered care for substance use disorder treatment: findings from a systematic scoping review. Subst Abuse Treat Prev Policy. 2019;14(1):37.
   PubMed Web of Science ®Google Scholar
• Gryczynski J, Schwartz RP, Salkever DS, Mitchell SG, Jaffe JH. Patterns in admission delays to outpatient methadone treatment in the United States. J Subst Abuse Treat. 2011;41(4):431–439.
   PubMed Web of Science ®Google Scholar
• Cioe K, Biondi BE, Easly R, Simard A, Zheng X, Springer SA. A systematic review of patients’ and providers’ perspectives of medications for treatment of opioid use disorder. J Subst Abuse Treat. 2020;119:108146.
   PubMed Web of Science ®Google Scholar
• Pro G, Zaller N. Interaction effects in the association between methadone maintenance therapy and experiences of racial discrimination in US healthcare settings. PLoS One. 2020;15(2):e0228755.
   PubMed Web of Science ®Google Scholar
• Priest KC, Englander H, McCarty D. Now hospital leaders are paying attention: a qualitative study of internal and external factors influencing addiction consult services. J Subst Abuse Treat. 2020;110:59–65.
   PubMed Web of Science ®Google Scholar
• Samet JH, Botticelli M, Bharel M. Methadone in primary care – one small step for congress, one giant leap for addiction treatment. N Engl J Med. 2018;379(1):7–8.
   PubMed Web of Science ®Google Scholar
• Calcaterra S, Bach P, Chadi A, et al. Methadone matters: what the United States can learn from the global effort to treat opioid addiction. J Gen Intern Med. 2019;34(6):1039–1042.
   PubMed Web of Science ®Google Scholar
• HHS Releases New Buprenorphine Practice Guidelines, Expanding Access to Treatment for Opioid Use Disorder [press release]. 2021.
   Google Scholar
• Jordan A, Mathis ML, Isom J. Achieving mental health equity: addictions. Psychiatr Clin North Am. 2020;43(3):487–500.
   PubMedGoogle Scholar
• Jordan A, Babuscio T, Nich C, Carroll KM. A feasibility study providing substance use treatment in the Black church. J Subst Abuse Treat. 2021;124:108218.
   PubMedGoogle Scholar
• Wen H, Hockenberry JM, Borders TF, Druss BG. Impact of medicaid expansion on medicaid-covered utilization of buprenorphine for opioid use disorder treatment. Med Care. 2017;55(4):336–341.
   PubMed Web of Science ®Google Scholar
• Earp BD, Lewis J, Hart CL. Racial justice requires ending the war on drugs. Am J Bioethics. 2021;2021:1–29.
   Google Scholar
• Culbert L. Fumano D. B.C. to offer Canada’s first, permanent safe drug supply in response to overdose crisis. Vancouver Sun. 2021.
   Google Scholar
• Bluthenthal RN. Structural racism and violence as social determinants of health: conceptual, methodological and intervention challenges. Drug Alcohol Depend. 2021;222:108681.
   PubMedGoogle Scholar
• Glied S, Lleras-Muney A. Technological innovation and inequality in health. Demography 2008;45(3):741–761.
   PubMed Web of Science ®Google Scholar
• Atkins R. Instruments measuring perceived racism/racial discrimination: review and critique of factor analytic techniques. Int J Health Serv. 2014;44(4):711–734.
   PubMed Web of Science ®Google Scholar
• Groos M, Wallace M, Hardeman R, Theall KP. Measuring inequity: a systematic review of methods used to quantify structural racism. J Health Disparit Res Pract 2018;11(2):13.
   Google Scholar
• Cheng HG, Phillips MR. Secondary analysis of existing data: opportunities and implementation. Shanghai Arch Psychiatry. 2014;26(6):371–375.
   PubMedGoogle Scholar
• National Academies of Sciences E, Medicine. Communities in Action: Pathways to Health Equity. Washington, DC: National Academies Press; 2017.
   Google Scholar
• Klinger EV, Carlini SV, Gonzalez I, et al. Accuracy of race, ethnicity, and language preference in an electronic health record. J Gen Intern Med. 2015;30(6):719–723.
   PubMed Web of Science ®Google Scholar
• King C, Englander H, Priest KC, Korthuis PT, McPherson S. addressing missing data in substance use research: a review and data justice-based approach. J Addict Med. 2020;14(6):454–456.
   PubMedGoogle Scholar
• Nobles M. History counts: a comparative analysis of racial/color categorization in US and Brazilian censuses. Am J Public Health. 2000;90(11):1738–1745.
   PubMed Web of Science ®Google Scholar
• Englander H, King C, Nicolaidis C, et al. Predictors of opioid and alcohol pharmacotherapy initiation at hospital discharge among patients seen by an inpatient addiction consult service. J Addict Med. 2020;14(5):415–422.
   PubMed Web of Science ®Google Scholar
• Joudrey PJ, Chadi N, Roy P, et al. Pharmacy-based methadone dispensing and drive time to methadone treatment in five states within the United States: a cross-sectional study. Drug Alcohol Depend. 2020;211:107968.
   PubMed Web of Science ®Google Scholar